We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+6.42%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$1.45B
AUM Growth
+$336M
Cap. Flow
+$603M
Cap. Flow %
41.48%
Top 10 Hldgs %
67.23%
Holding
768
New
375
Increased
70
Reduced
59
Closed
238

Top Buys

Rank Stock Value
1
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$151M
2
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$48.3M
3
ITOS
iTeos Therapeutics
ITOS
+$21.3M
4
QNGY
Quanergy Systems, Inc.
QNGY
+$11.5M
5
FULC icon
Fulcrum Therapeutics
FULC
+$10.9M

Top Sells

Rank Stock Value
1
SMH icon
VanEck Semiconductor ETF
SMH
+$30.8M
2
DIS icon
Walt Disney
DIS
+$23.1M
3
NGHC
National General Holdings Corp
NGHC
+$20.7M
4
STLA icon
Stellantis
STLA
+$19.7M
5
SVOKU
Seven Oaks Acquisition Corp. Unit
SVOKU
+$16M

Sector Composition

Rank Sector Weight
1 Healthcare 11.15%
2 Financials 9.75%
3 Technology 2.87%
4 Industrials 2.67%
5 Consumer Discretionary 1.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FOREU
26
DELISTED
Foresight Acquisition Corp. Units
FOREU
$6.67M 0.46%
+673,440
New +$6.82M
TELA icon
27
TELA Bio
TELA
$38.9M
$5.98M 0.41%
401,376
-400
-0.1% -$6.02K
RLMD icon
28
Relmada Therapeutics
RLMD
$527M
$5.88M 0.4%
+166,942
New +$5.84M
BSX icon
29
Boston Scientific
BSX
$71.5B
$5.4M 0.37%
+139,705
New +$5.29M
BBVA icon
30
Banco Bilbao Vizcaya Argentaria
BBVA
$156B
$5.22M 0.36%
1,000,000
– –
APYX icon
31
Apyx Medical
APYX
$171M
$5.04M 0.35%
522,042
+18,961
+4% +$190K
ENIA
32
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
$4.65M 0.32%
+548,700
New +$4.37M
NUVB icon
33
Nuvation Bio
NUVB
$2.32B
$4.26M 0.29%
408,125
+378,125
+1,260% +$4.23M
YAC
34
DELISTED
Yucaipa Acquisition Corporation Class A Ordinary Shares
YAC
$3.69M 0.25%
375,000
+326,384
+671% +$3.38M
LAZR
35
DELISTED
Luminar Technologies
LAZR
$3.65M 0.25%
+10,000
New +$4.52M
SAN icon
36
Banco Santander
SAN
$210B
$3.53M 0.24%
1,029,560
– –
MRTX
37
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$3.48M 0.24%
+20,324
New +$4.02M
IQ icon
38
iQIYI
IQ
$1.28B
$3.31M 0.23%
+198,955
New +$4.6M
CHNGU
39
DELISTED
Change Healthcare Inc. Tangible Equity Units
CHNGU
$3.28M 0.23%
43,796
– –
ALXN
40
DELISTED
Alexion Pharmaceuticals
ALXN
$3.14M 0.22%
20,554
+13,961
+212% +$2.16M
SRSA
41
DELISTED
Sarissa Capital Acquisition Corp. Class A Ordinary Shares
SRSA
$3.09M 0.21%
+305,697
New +$3.22M
GRNA
42
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
$2.91M 0.2%
+300,000
New +$2.94M
BTAQ
43
DELISTED
Burgundy Technology Acquisition Corporation Class A Ordinary shares
BTAQ
$2.85M 0.2%
+288,189
New +$3.06M
PRST
44
DELISTED
Presto Technologies, Inc. Common Stock
PRST
$2.74M 0.19%
+280,000
New +$2.8M
PTK
45
DELISTED
PTK Acquisition Corp.
PTK
$2.56M 0.18%
+260,000
New +$2.64M
FSSIU
46
DELISTED
Fortistar Sustainable Solutions Corp. Unit
FSSIU
$2.53M 0.17%
+254,892
New +$2.66M
TSIBU
47
DELISTED
Tishman Speyer Innovation Corp. II Unit
TSIBU
$2.5M 0.17%
+250,000
New +$2.58M
CGRO
48
DELISTED
Collective Growth Corporation Class A Common Stock
CGRO
$2.49M 0.17%
+250,000
New +$3.13M
GPGI
49
GPGI Inc
GPGI
$4.35B
$2.49M 0.17%
+300,970
New +$2.56M
FLME.U
50
DELISTED
Flame Acquisition Corp. Units, each consisting of one share of Class A Common Stock, and one-half of one Warrant
FLME.U
$2.48M 0.17%
+250,000
New +$2.5M
1
2
3 4 5

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q1 2021 Portfolio in Review

As of Q1 2021, Cowen and Company held 768 positions worth $1.45B, up 30% from $1.12B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Cowen and Company deployed $603M of net new capital in Q1 2021, opening 375 new positions and adding to 70 existing holdings. Its largest new stake was iTeos Therapeutics: 588,238 shares worth $20.1M.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 4.9% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Freeport-McMoran, an estimated $5.42M trimmed.

  • Cowen and Company's largest Q1 2021 buy was iTeos Therapeutics: 588,238 shares worth $20.1M.
  • Cowen and Company added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q1 2021, an estimated $151M increase.
  • Cowen and Company's biggest Q1 2021 reduction was Freeport-McMoran, cutting an estimated $5.42M.
  • Cowen and Company fully exited VanEck Semiconductor ETF in Q1 2021, selling an estimated $30.8M.
  • Cowen and Company's ten largest holdings make up 67% of its $1.45B portfolio in Q1 2021.
  • Cowen and Company opened 375 new positions and closed 238 in Q1 2021.
  • Cowen and Company's portfolio value rose 30% quarter-over-quarter to $1.45B.

Based on Cowen and Company's 13F filing for Q1 2021, filed 4 May 2021.